adalimumab vs levothyroxine
According to this portal's Publishing Organization, this page was last reviewed in August 2026 against our methodology. Figures and extracts on this site, including tables above 1,000 rows when the corpus is that large, are the publisher's responsibility.
Side-by-side comparison of adalimumab and levothyroxine. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Humira
Synthroid, Levoxyl, Tirosint
Idacio is a medicine that blocks a protein called TNF. It is used to treat several diseases, including arthritis and Crohn's disease.
Levothyroxine is a medicine that replaces a hormone normally made by your thyroid gland. It is used when the thyroid doesn't make enough hormone on its own.
Idacio can help adults with rheumatoid arthritis by reducing joint pain and damage. It can also help children (2 years and older) with juvenile idiopathic arthritis. Idacio treats psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa and uveitis.
This medicine treats hypothyroidism, a condition where the thyroid gland doesn't make enough thyroid hormone. It can be used in adults and children, even newborns. Levothyroxine can also be used after surgery and radioiodine therapy for thyroid cancer to help lower thyroid-stimulating hormone (TSH) levels.
Idacio works by blocking a protein in your body called tumor necrosis factor (TNF). TNF can cause inflammation and damage in certain diseases. By blocking TNF, Idacio can reduce these symptoms.
Levothyroxine provides a synthetic form of thyroxine (T4), which is the main hormone produced by the thyroid gland. Your body converts T4 into triiodothyronine (T3), the active form of the hormone. By providing T4, levothyroxine helps restore normal thyroid hormone levels in your body.
- • Infections (like colds or sinus infections)
- • Injection site reactions (redness, itching, pain, or swelling)
- • Headache
- • Rash
- • Fatigue
- • Increased appetite
- • Weight loss
- • Feeling hot
- • Headache
- Pain 49,062
- Arthralgia 48,039
- Injection Site Pain 47,251
- Fatigue 39,111
- Rheumatoid Arthritis 35,573
- Fatigue 25,847
- Nausea 22,026
- Headache 18,797
- Diarrhoea 18,176
- Dyspnoea 16,216
Idacio can increase your risk of serious infections that could lead to hospitalization or death. Tell your doctor if you have any infections before starting Idacio. Idacio may also increase your risk of certain cancers, including lymphoma. Children and teens taking TNF blockers like Idacio have developed rare, aggressive cancers.
Thyroid hormones, including levothyroxine, should not be used for weight loss or to treat obesity. Using high doses can cause serious and life-threatening side effects, especially when taken with stimulant medicines.
Tell your doctor if you are pregnant or plan to become pregnant. Idacio can cross the placenta and may affect your baby's immune system. Talk to your doctor about vaccines for your baby if you took Idacio during pregnancy.
Tell your doctor if you are pregnant or plan to become pregnant. Your levothyroxine dose may need to be adjusted during pregnancy. Levothyroxine passes into breast milk, but it is not expected to harm the baby.
Also Compare, Nearby Drugs
Compare adalimumab with
How to Read This adalimumab vs levothyroxine Comparison
adalimumab is classified in the TNF-Alpha Inhibitor (Biologic) drug class, while levothyroxine sits within the Thyroid Hormone class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, adalimumab has 219,036 submissions while levothyroxine has 101,062. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for adalimumab or levothyroxine.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.